Table 6.
19 Kyoto Encyclopedia of Genes and Genomes KEGG pathways associated with 6 predicted targets of WDD.
| Pathway ID | Term | Pathway Class | Degree |
|---|---|---|---|
| hsa03320 | PPAR signaling pathway | Endocrine system | 6 |
| hsa04919 | Thyroid hormone signaling pathway | Endocrine system | 1 |
| hsa04920 | Adipocytokine signaling pathway | Endocrine system | 2 |
| hsa0492 | Glucagon signaling pathway | Endocrine system | 1 |
| hsa04932 | Non-alcoholic fatty liver disease (NAFLD) | Endocrine and metabolic diseases | 4 |
| hsa04024 | cAMP signaling pathway | Signal transduction | 1 |
| hsa04151 | PI3K-Akt signaling pathway | Signal transduction | 1 |
| hsa04152 | AMPK signaling pathway | Signal transduction | 1 |
| hsa04310 | Wnt signaling pathway | Signal transduction | 1 |
| hsa04380 | Osteoclast differentiation | Development | 1 |
| hsa04976 | Bile secretion | Digestive system | 1 |
| hsa05016 | Huntington’s disease | Neurodegenerative diseases | 1 |
| hsa05160 | Hepatitis C | Infectious diseases | 4 |
| hsa05200 | Pathways in cancer | Cancers | 3 |
| hsa05202 | Transcriptional misregulation in cancer | Cancers | 2 |
| hsa05216 | Thyroid cancer | Cancers | 2 |
| hsa05221 | Acute myeloid leukemia | Cancers | 1 |
| hsa05222 | Small cell lung cancer | Cancers | 1 |
| hsa05223 | Non-small cell lung cancer | Cancers | 1 |